←
Dr John O'Donohue2,697 posts
Dr John O'Donohue avatar

Dr John O'Donohue

@TheBottomDoc

Gastroenterologist. Shining a light on bowel cancer. Inspector of endoscopy units, stomachs & bile ducts too. Some tweets my own.

◷ Joined December 2014▧ 520 Photos and videos
David Beaton avatar
⟳ Dr John O'Donohue retweeted
David Beaton@davidbeaton87·14 Apr 2025

🧵1/6 🚨 New from the British Society of Gastroenterology: We analysed all UK colonoscopies from the National Endoscopy Database (2019–2020). That’s over 592,000 procedures. Findings below 👇 (📄 Free article link (limited time): authors.elsevier.com/c/1ktHw…)

Dr John O'Donohue avatar
Dr John O'Donohue@TheBottomDoc·20 May 2024

How to identify the ‘sensory phenotype’ in bloating, and how to treat it: Duloxetine, not SSRI, is best if diet and diaphragmatic breathing isn’t enough and pharmaceutical treatment needed Kyle Staller, Mass General @DDWMeeting

Post attachmentPost attachment
Dr John O'Donohue avatar
Dr John O'Donohue@TheBottomDoc·20 May 2024

What’s different between patients with bloating & normal controls? Fernando Azpiroz, Hspital Val d’Hebron @DDWMeeting Not amount of gas, or biomass. It’s sensitivity to distension. Perceived distension can be obesity, or descent of diaphragm (abdominophrenic dyssynergia)

Post attachmentPost attachment
Dr John O'Donohue avatar
Dr John O'Donohue@TheBottomDoc·19 May 2024

Not all FODMAPs are equal! Can we simplify FODMAP restriction in IBS-D? Prashant Singh, Un of Michigan @DDWMeeting FODMAP restriction difficult and can result in micronutrient malnutrition In reintroduction phase, most symptoms due to fructans & galacto-oligosaccharides

Post attachment
Dr John O'Donohue avatar
Dr John O'Donohue@TheBottomDoc·18 May 2024

Heather Patton, VA San Diego, CA @DDWMeeting All patients with compensated cirrhosis should be subclassified as with or without Clinically Significant Portal Hypertension (CSPH) - and pharmacotherapy used (eg carvedilol) to lower portal pressure Note NEW terminology!

Post attachmentPost attachmentPost attachment
Dr John O'Donohue avatar
Dr John O'Donohue@TheBottomDoc·18 May 2024

However, 40% of patients do not respond adequately to UDCA. Pruritus can be exacerbated by Obeticholic Acid - which can’t be used with decompensated cirrhosis. Elafibrinor, a PPAR agonist, shows promise and improves pruritus.

Dr John O'Donohue avatar
Dr John O'Donohue@TheBottomDoc·18 May 2024

Don’t need endoscopy to screen for varices in patients with cirrhosis any more - Dr Willscott Naugler, Portland, ON @DDWMeeting Concept of ‘Clinically significant Portal Hypertension’ - if > 10 mm Hg elevation is present, start on beta blockers to prevent varices, ascites

Post attachment